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be noticed. Some of them were CD68-immunoreactive while others were
both vimentin- and S-100 immunoreactive. Our results show significant
hypocellularity in subendothelium, followed by apoptotic smooth muscle
cells and CD3 and CD45 immunoreactivity.
Conclusion: Some of foam cells in atherosclerotic aortic aneurysm
develop from monocyte-macrophage lineage (CD68-immunoreactive)
while others originate from smooth muscle cells (vimentin and S-
100-immunoreactive). The smooth muscle cells show synthetic phenotype.
Diminuation in cell numbers is the result of necrosis and apoptosis.
Keywords: atherosclerotic aortic aneurysm, smooth muscle cells, re-
modeling.
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Background and Aims: Skin autofluorescence (AF) is a non-invasive
marker for Advanced Glycation Endproducts which are protein bound
compounds derived from glycaemic and oxidative stress. We aimed to
assess whether skin AF is associated with carotid intima media thickness
(IMT) and vascular risk factors (VRFs), and complements cardiovascular
risk scores in identifying subjects with increased IMT.
Methods: This was a cross-sectional local sub study to the “Carotid
Intima Media Thickness and IMT-Progression as Predictors of Vascular
Events in a High Risk European Population (IMPROVE)” study. 186
subjects with ≥3 VRFs without a history of cardiovascular disease (CVD)
were included. Skin AF was measured on the lower arm, using a prototype
of the current AGE-Reader. IMT was measured with a high-resolution
ESAOTE ultrasound system.
Results: Skin AF correlated with IMT (r=0.15; P=0.039), C-reactive
protein (r=0.19; P=0.015), leukocyte count (r=0.27; P<0.001), waist cir-
cumference (r=0.24; P=0.002), BMI (r=0.25; P=0.001), and fasting glucose
(r=0.21; P=0.007), and was higher in smokers (P=0.038), even after
correction for age. Combining FRS or SCORE with skin AF improved the
prediction of IMT (see figure).
Conclusion: Skin AF is age independently associated with carotid IMT,
inflammation, and VRFs, and may add incremental information to global
risk assessment scores in identifying asymptomatic subjects at high risk for
CVD.
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Objective: We compared the presence of carotid artery plaque to Framing-
ham global 10-year CHD risk estimates (FRS) in determining the level of
CV risk in patients with metabolic syndrome (MS).
Methods: Patients referred to our prevention clinic were evaluated for
metabolic syndrome by the ATP III criteria and evaluated for risk using
FRS and digital B-mode ultrasound to identify the presence of carotid
artery plaque. Plaque was defined as an area of intima-media thickness
(IMT) ≥ 1.2mm. Framingham 10-year risk categories included moderate
risk (<10%), moderately high risk (10-20%) and high risk (>20%).
Results: A total of 100 patients at baseline met inclusion criteria. Mean
age was 57±9 years; male, 66%; waist circumference (WC): > 40/35
inches (males/females), 63%; diabetes, 18.6%; current smokers, 7.8%;
hyperlipidemia, 99%; and, hypertensive, 91%. Initial WC, HDL-C, TG,
SBP, DBP, and glucose: 41±5 in, 47±14 mg/dL, 176±109 mg/dL, 134±14
mmHg, 85±12 mmHg, and 101±14 mg/dL, respectively. Carotid plaque
was identified in 84.0% of the patients. MS patients with plaque included
thirty-three of the forty-three moderate (<10%) FRS patients, twenty-three
of twenty-four moderately high (10-20%) FRS patients, and twenty-eight of
thirty-three high risk (>20%) FRS patients. Thus, 56% of the MS patients
who were not identified as high risk by FRS were actually found to be high
risk with an IMT ≥ 1.2mm.
Conclusion: Carotid IMT is a powerful adjunct clinical tool to FRS in
determining CV risk in metabolic syndrome patients.
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We tested the extent to which plasma adipokine levels contribute to the
increased carotid artery intima media thickness (IMT) associated with type
2 diabetes mellitus and with male gender, independently of conventional
cardiovascular risk factors, insulin resistance and plasma C-reactive protein
(CRP).
In 84 type 2 diabetic patients and 85 control subjects, IMT (mean of
3 segments of both carotid arteries by ultrasonography), insulin resistance
(HOMAir), plasma CRP, lipids, adiponectin, leptin, resistin and tumor
necrosis factor-alpha (TNF-alpha) were measured. In diabetic patients, IMT
(p < 0.001), mean arterial pressure (p < 0.001), HOMAir (p < 0.001),
plasma CRP (p = 0.003), triglycerides (p = 0.037), leptin (p = 0.023),
resistin (p = 0.003) and TNF-alpha (p = 0.003) levels were higher, whereas
HDL cholesterol (p < 0.001) and adiponectin (p < 0.001) were lower
compared to control subjects. Plasma adiponectin (p < 0.001) and leptin
(p < 0.001) were substantially lower in men than in women. IMT was
positively and independently associated with age (p < 0.001), diabetes (p =
0.049) and male gender (p = 0.002) in a multivariate regression model, not
including other variables. Further analyses showed that IMT was positively
determined by age (p < 0.001) and triglycerides (p = 0.038) and negatively
determined by adiponectin (p < 0.001), without independent effects of
diabetes, gender and HOMAir.
In conclusion, increased IMT in type 2 diabetes may to a considerable
extent be explained by lower plasma adiponectin and higher triglycerides,
but not by leptin, resistin and TNF-alpha. The gender effect on IMT is
related to lower plasma adiponectin.
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